These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19713673)

  • 1. Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome.
    Kinoshita M; Ohnishi H; Maeda T; Yoshimura N; Takeoka Y; Yasuda D; Kusano J; Mashimo Y; Saito S; Shimamoto K; Teramoto T
    J Atheroscler Thromb; 2009 Aug; 16(4):517-22. PubMed ID: 19713673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
    Castro Cabezas M; Erkelens DW; Kock LA; De Bruin TW
    Eur J Clin Invest; 1994 Oct; 24(10):669-78. PubMed ID: 7851467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.
    Smith D; Watts GF; Dane-Stewart C; Mamo JC
    Eur J Clin Invest; 1999 Mar; 29(3):204-9. PubMed ID: 10202376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evidence for chylomicrons as mediators of postprandial inflammation.
    de Vries MA; Klop B; Alipour A; van de Geijn GJ; Prinzen L; Liem AH; Valdivielso P; Rioja Villodres J; Ramírez-Bollero J; Castro Cabezas M
    Atherosclerosis; 2015 Dec; 243(2):540-5. PubMed ID: 26523991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study.
    Simons LA; Dwyer T; Simons J; Bernstein L; Mock P; Poonia NS; Balasubramaniam S; Baron D; Branson J; Morgan J
    Atherosclerosis; 1987 May; 65(1-2):181-9. PubMed ID: 3496893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
    Couillard C; Bergeron N; Bergeron J; Pascot A; Mauriège P; Tremblay A; Prud'homme D; Bouchard C; Després JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4575-82. PubMed ID: 11134111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals.
    Masuda D; Nishida M; Arai T; Hanada H; Yoshida H; Yamauchi-Takihara K; Moriyama T; Tada N; Yamashita S
    J Atheroscler Thromb; 2014; 21(6):618-27. PubMed ID: 24573016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence.
    Masuda D; Sugimoto T; Tsujii K; Inagaki M; Nakatani K; Yuasa-Kawase M; Tsubakio-Yamamoto K; Ohama T; Nishida M; Ishigami M; Kawamoto T; Matsuyama A; Sakai N; Komuro I; Yamashita S
    Eur J Clin Invest; 2012 Sep; 42(9):992-9. PubMed ID: 22587365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for increased chylomicron remnants in rheumatoid arthritis.
    Burggraaf B; van Breukelen-van der Stoep DF; van Zeben J; van der Meulen N; van de Geijn GM; Liem A; Valdivielso P; Rioja Villodres J; Ramírez-Bollero J; van der Zwan E; Castro Cabezas M
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29231984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls.
    Valdivielso P; Puerta S; Rioja J; Alonso I; Ariza MJ; Sánchez-Chaparro MA; Palacios R; González-Santos P
    Clin Chim Acta; 2010 Mar; 411(5-6):433-7. PubMed ID: 20059992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet.
    Madigan C; Ryan M; Owens D; Collins P; Tomkin GH
    Diabetes Care; 2000 Oct; 23(10):1472-7. PubMed ID: 11023139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.
    Phillips C; Bennett A; Anderton K; Owens D; Collins P; White D; Tomkin GH
    Metabolism; 2002 Jul; 51(7):847-52. PubMed ID: 12077729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects.
    Otokozawa S; Ai M; Diffenderfer MR; Asztalos BF; Tanaka A; Lamon-Fava S; Schaefer EJ
    Metabolism; 2009 Nov; 58(11):1536-42. PubMed ID: 19592048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of pentraxin 3 serum concentration in men and women with type 2 diabetes.
    Waluś-Miarka M; Trojak A; Miarka P; Kapusta M; Kawalec E; Idzior-Waluś B; Małecki MT
    Innate Immun; 2020 Jul; 26(5):351-357. PubMed ID: 31874582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing elevated serum apolipoprotein B48 in diabetic and control participants.
    Leonard A; Tun TK; Gaffney R; Sharma J; Gibney J; Boran G
    Br J Biomed Sci; 2014; 71(4):145-50. PubMed ID: 25562991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome.
    Irawati D; Mamo JC; Dhaliwal SS; Soares MJ; Slivkoff-Clark KM; James AP
    Lipids Health Dis; 2016 Sep; 15(1):169. PubMed ID: 27686975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.